US FDA Might Face Funding Penalty For Missing User Fee Goals
Executive Summary
Industry representatives support adding a provision to the user fee agreements that would withdraw some taxpayer funding if the agency does not meet its deliverables.
You may also be interested in...
Sen. Burr Worries Rising User Fees Helping US FDA Evade Congressional Oversight
Burr wants more FDA accountability in the new user fee agreements and questions whether they benefit patients. Generic approval modifications get attention at hearing.
Sen. Burr Worries Rising User Fees Helping US FDA Evade Congressional Oversight
Burr wants more FDA accountability in the new user fee agreements and questions whether they benefit patients. Generic approval modifications get attention at hearing.
Congress Already Preparing For User Fee Bills
Multiple congressional offices attended a briefing on GDUFA III with FDA and industry officials, suggesting plans for the must-pass bill already are in the works.